News & Updates
Filter by Specialty:
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
Children with Staphylococcus aureus bacteraemia (SAB), a common complication of acute hematogenous osteomyelitis (AHO), are vulnerable to a wide range of illnesses, suggests a study. Thus, classifying its severity may aid in treatment decision-making.
Early transition to oral antimicrobials prevents treatment failure in children with SAB, AHO
27 Aug 2022
Adjuvant sorafenib after RFA boosts survival in recurrent hepatocellular carcinoma
The use of sorafenib as an adjuvant therapy after radiofrequency ablation (RFA) appears to improve survival outcomes in patients with recurrent hepatocellular carcinoma who underwent hepatectomy, according to a study.
Adjuvant sorafenib after RFA boosts survival in recurrent hepatocellular carcinoma
27 Aug 2022
UK Biobank: As hard water levels increase, so does the burden of eczema
Exposure to domestic hard water in high concentrations appears to go with a corresponding increase in the prevalence of eczema in adults, as reported in a UK study.
UK Biobank: As hard water levels increase, so does the burden of eczema
26 Aug 2022
Pimavanserin trumps atypical antipsychotics in preventing death in Parkinson’s disease patients
Use of pimavanserin appears to be more effective than atypical antipsychotic agents in reducing mortality among Parkinson’s disease patients during the first 180 days of treatment, reveals a study. However, such benefit is seen only in community-dwelling patients and not in nursing home residents.
Pimavanserin trumps atypical antipsychotics in preventing death in Parkinson’s disease patients
26 Aug 2022
Appeal to emotion, interpersonal relevance important in diabetes risk communication
Communicating the risks of type 2 diabetes needs to be done in an emotionally impactful way while also having an interpersonal appeal, according to a recent Singapore study. To improve the uptake of healthy lifestyle practices, shifting from a long-term view of the disease to more short-term, observable benefits may be valuable.
